Resources

The Years Ahead in Biomedical HIV Prevention Research

This graphic shows the updated status of large-scale prevention trials through the end of 2024.

Years Ahead in HIV Prevention Research: Time to Market

This timeline shows the potential time points when the next-generation of HIV prevention options might find their way into new programs.

From the Lab to the Jab

From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats.

Local Vaccine Production: Harnessing Its Potential for Equity

This issue brief on local vaccine production covers the current state of local production, what is needed to facilitate it, and ideas for advocacy to harness its potential.

mRNA Technology: What It Might Mean for Future Vaccines

This issue brief on mRNA technology covers what it is, how it works, current knowledge gaps and ideas for advocacy to harness its potential.

Vaccine Access: What’s Working and What’s Next

This issue brief covers the web of issues that influence access to vaccines.

Vaccine Research and Development: Key Lessons and Ways Forward

This issue brief on the vaccine research and development (R&D) process is one of a series of four briefs.

The HIV Prevention Pipeline

This graphic shows currently available options for HIV prevention, newly approved and recommended treatment, and those in development.

Phase 1 mRNA HIV Vaccine Trials

A snapshot of early phase trials testing mRNA-based HIV vaccines.

Pregnant and Lactating People (PLP) in Ongoing HIV Prevention Trials